Wilson's disease is an autosomal recessive hereditary genetic disorder that causes abnormal copper accumulation primarily in the liver and central nervous system. The incidence of the disease is rare, with 1% of 30000 people affected. We plan to provide prospective data collection with patients diagnosed with Wilson's disease, with annual follow-up visits for 5 years. The registry records the results of the patient's eating and drinking habits, medication compliance, lifestyle, detailed anamnesis, medication management, and follow-up tests. The purpose of the Wilson registry is to collect multicentre data prospectively, to analyze the incidence of Wilson's disease epidemiology, drug therapy, drug-related side effects, and recognition of factors affecting disease progression.